文献速递肿瘤 PET/CT神经核医学

容积替代液联合68Ga-DOTA-Exendin-4 PET/CT显影良性胰岛素瘤

Volume Replacement Fluid Demarks Benign Insulinoma With 68Ga-DOTA-Exendin-4 PET/CT.
PubMed 文献 · Clin Nucl Med · 2019-01-01

一例47岁女性患者,反复神经低血糖症状28个月,空腹试验确诊内源性高胰岛素性低血糖,高度怀疑胰岛素瘤。既往MRI、超声内镜、In-pentetreotide SPECT/CT及68Ga-DOTA-exendin-4 PET/CT均未显示胰岛素瘤。输注胶体容积替代液(Gelofusine)后重复68Ga-DOTA-exendin-4 PET/CT,使胰岛素瘤从左肾背景中显现,得以手术治愈。

要点

  • 68Ga-DOTA-exendin-4 PET/CT可用于胰岛素瘤定位。
  • 输注Gelofusine可减少肾脏摄取,有助于发现左肾旁胰岛素瘤。
  • 对于常规影像阴性的胰岛素瘤,可考虑容积替代液辅助显像。

核心结论

  • 输注胶体容积替代液后重复68Ga-DOTA-exendin-4 PET/CT,可使左肾旁的胰岛素瘤从肾脏背景中显现,并成功引导手术治愈。

研究设计与样本

  • 个案报道:47岁女性,反复神经低血糖症状28个月,空腹试验确诊内源性高胰岛素性低血糖。

主要发现

  • 既往MRI、超声内镜、In-pentetreotide SPECT/CT及68Ga-DOTA-exendin-4 PET/CT均未显示胰岛素瘤。
  • 输注Gelofusine后重复68Ga-DOTA-exendin-4 PET/CT,胰岛素瘤从左肾背景中显现。

临床怎么用

  • 对于临床高度怀疑但常规影像阴性的胰岛素瘤,可尝试输注Gelofusine后重复68Ga-DOTA-exendin-4 PET/CT以改善左肾旁病灶的检出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Insulinomas are often difficult to localize. We present a 47-year-old woman who had recurrent neuroglycopenic symptoms and positive Whipple triad for 28 months. The 14 hours of fasting test confirmed the diagnosis of endogenous hyperinsulinemic hypoglycemia which is highly suspicious for the presence of an insulinoma. Previously performed MRI, endoscopic ultrasound, In-pentetreotide SPECT/CT, and Ga-DOTA-exendin-4 PET/CT did not show any evidence of an insulinoma. Subsequently, Ga-DOTA-exendin-4 PET/CT was repeated with the previous infusion of a colloidal volume replacement fluid (Gelofusine), known to reduce Ga-DOTA-exendin-4 accumulation in the kidneys. Consequently, the insulinoma was unmasked from the left kidney, allowing curative surgery.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Antwi K, Nicolas G, Fani M, et al. Volume Replacement Fluid Demarks Benign Insulinoma With 68Ga-DOTA-Exendin-4 PET/CT. Clin Nucl Med. 2019. PMID: 30889001. doi:10.1097/RLU.0000000000002522

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。